Rozerem tablets 8 mg for insomnia (ramelteon)

What are Rozerem tablets 8mg for insomnia (ramelteon)?

Rozerem tablets, a medication containing the active compound ramelteon, offer a unique and effective approach to promoting sleep without inducing sedation. Ramelteon acts as a melatonin receptor antagonist, specifically targeting the MT1 and MT2 receptors of the suprachiasmatic nucleus in the brain. By binding to these receptors, the drug mimics the action of endogenous melatonin, which plays a critical role in regulating the sleep-wake cycle.

The suprachiasmatic nucleus is a key component of the body's internal clock, known as the circadian rhythm, which governs the natural sleep-wake patterns. By interacting with the MT1 and MT2 receptors, Rozerem helps to reset the circadian rhythm, thus promoting improved sleep quality and duration. Unlike traditional sedative sleep aids, Rozerem's mechanism of action does not result in a drowsy or sedated feeling upon waking up, making it a preferred choice for many individuals seeking a natural and non-habit-forming sleep aid.

Clinical studies have demonstrated the effectiveness of Rozerem in treating sleep disturbances. Users of the medication reported a significant reduction in the time it takes to fall asleep, as well as an overall increase in total sleep duration. Moreover, unlike some other sleep medications, Rozerem has not been associated with disruptions in the normal sleep architecture.

Another noteworthy aspect of Rozerem's profile is its rarity as a sleep agent within its category. While most sleep medications act as sedatives, Rozerem stands out as a specific melatonin receptor antagonist, offering a novel approach to tackling sleep problems. The safety profile of ramelteon has also been extensively studied, with research consistently showing that it is well-tolerated and does not lead to the development of dependency or abuse potential. As a result, Rozerem has not been listed as a controlled drug, providing further reassurance for both healthcare providers and patients.

Active principles: ramelteon

Amount: 100 tablets

Maker: Takeda Pharmaceutical Co., Ltd., Tokyo, Japan

Indications: treatment of insomnia

How to take

Adults should take one tablet a day, strictly before bedtime. Even if you're still awake, do not take more medicine. 

Contraindications: do not use for the following patients:

• breastfeeding and pregnant women,
• patients with liver disease,
• patients with sleep apnea syndrome,
• patients with brain disorders.

Important information

Take the medicine only after eating or while you are still eating. If you plan to be up within a few hours, do not take this medication.

As this medicine can cause sleepiness, patient should not drive a car, work at heights, or operate dangerous machinery the morning after taking it. 

Avoid consuming alcohol while taking this medicine. 

If an allergic reaction occurs, patient needs to stop using the medicine and consult with their doctor. If patient is taking any other medication or treatment, they should consult with their doctor in advance.